Back to ESPR

Esperion Therapeutics, Inc. 10-Q

Accession 0001628280-24-036762

Filing information

CIK
0001434868
Report date
2024-06-30
Filing date
2024-08-12
Form
10-Q
Primary document
espr-20240630.htm

Open primary document

View the filing document on sec.gov.

Open EDGAR directory

Inspect all files for this filing.

Complete submission file

Open the raw SEC submission text.